Government

Articles

On Wednesday, August 30th, the Department of Health and Human Services made its recommendation to the Drug Enforcement Agency to classify cannabis as a Schedule III drug, paving the way for reform, industry expansion, and research opportunities.

Shifting Tides: US Department of Health and Human Services Recommends Cannabis Rescheduling from Schedule I to Schedule III

The recently approved legislation creates new opportunities for possession and cultivation.

Germany Moves Towards Cannabis Legalization

Several agencies are reportedly working together to review the scheduling of cannabis, with a final decision anticipated to come later this year.

Potential Timeline and Projected Results Regarding the Federal Review of Cannabis Scheduling

The New Jersey Business Action Center (NJBCA) recently announced Tauhid Chappell as the first Executive Director of its Cannabis Training Academy (CTA). 

Executive Director Announced for the New Jersey Cannabis Training Academy

If passed, possession of psilocybin would be legal in certain circumstances in the state. 

Bill That Would Legalize Psilocybin Approved in Rhode Island

Sponsored by 17 state lawmakers, House resolution 420 called on federal officials to reschedule cannabis at the federal level.

Pennsylvania House Resolution Calls for Federal Rescheduling of Cannabis

After the most recent cannabis legalization bill failed to pass the Senate, Governor Sununu issued a statement explaining how legalization could occur instead.

New Hampshire Governor Outlines Path for Recreational Cannabis Legalization in the State

In early March 2023, the US Justice Department launched an online application for individuals who were pardoned for simple possession of cannabis under President Biden's October 6, 2022 proclamation. Applicants can now receive a certificate of proof of their pardon.

US Justice Department Launches Online Application for Certificate of Proof of Cannabis Possession Pardon

The House and Senate introduced a revised bill to mandate Veterans Affairs (VA) to conduct research on the effects of medical cannabis on veterans with post-traumatic stress disorder (PTSD) and chronic pain. 

House and Senate Introduce Bill to Direct Veterans Affairs to Study Medical Cannabis to Treat Certain Conditions

A statement released on Thursday, January 26, 2023 from Dr. Janet Woodcock, the principal deputy commissioner of the Food and Drug Administration (FDA), announced that the FDA will work with Congress in formulating regulatory oversight to balance risk and access for products in the cannabidiol (CBD) market.